Editor of Patient Care Online.
SGLT2 Inhibitors Outperformed Other Oral Antidiabetic Drugs for Persons with T2D, NAFLD: Daily Dose
Your daily dose of the clinical news you may have missed.
Apixaban and Aspirin Equal in Preventing Stroke Recurrence in Cardiopathy: Daily Dose
Weight Management Treatments Underused among Primary Care Patients with Obesity Despite Their Effectiveness
In a new study of primary care patients with obesity, bariatric surgery offered the greatest probability of 1-year weight loss of ≥5%, at 93%.
COVID-19 Hospitalization Raises Long-Term Mortality Risk Compared to Seasonal Flu: Daily Dose
CDC: One-Third of Children in US Received an HPV Vaccine Dose
According to a new CDC report, 38.6% of children aged 9-17 years received ≥1 doses of the HPV vaccine in 2022.
Eating Disorder Hospitalizations Increasing among US Adolescents: Daily Dose
New Scientific Statement from American Heart Association Raises Awareness of CVD Risks for Women
Women with adverse pregnancy outcomes face a significantly higher risk of cardiovascular disease and stroke later in life, according to the statement.
Young Infants, Children Born Prematurely Face Highest Risk for RSV Hospitalization: Daily Dose
Preventive Health Screenings Continue to Lag Post-Pandemic: Daily Dose
SGLT2 Inhibitors Outperformed Other Oral Antidiabetic Drugs for Patients with T2D and NAFLD, According to New Research
Findings suggest that SGLT2 inhibitors may be the preferred choice for patients with both T2D and NAFLD, reported researchers.
Tirzepatide Linked to “Impressive” BP Reduction in Adults with Obesity: Daily Dose
COVID-19 Hospitalization Linked to Higher Long-Term Mortality Risk Compared to Seasonal Influenza, Shows New Research
Hospitalization for COVID-19 was associated with higher long-term risks of death, adverse health outcomes, and significant cumulative excess DALYs vs influenza.
Cannabis Use and Risk of Prevalent Asthma: Daily Dose
13 Drugs Approved for Primary Care in 2023
Get a quick look at 13 of the many FDA-approved drugs in 2023 for conditions commonly seen in primary care.
Depression, IBD Combo Raises Risk of Hospital Readmission, Mortality: Daily Dose
Younger Infants and Children Born Prematurely at Highest Risk for RSV Hospitalization, According to New Study
Results showed nearly one-third of hospitalizations for acute respiratory illness among children aged <5 years were associated with RSV.
Survey Data Underscores Education Gap in Ulcerative Colitis for Primary Care Clinicians: Daily Dose
Noninvasive Tests May be Poor Predictor of Liver Fibrosis, Especially Among Black Adults
Using FIB-4 index first to screen for cirrhosis may lead to clinicians missing 48% of cases, according to a recent study.
Vagus Nerve Stimulation in Narcolepsy: Daily Dose
CDC: Gonorrhea Cases Declined for First Time in Decade, but Syphilis Keeps Climbing
Reported cases of chlamydia, syphilis, and gonorrhea in the US surpassed 2.5 million for the third time in 5 years, according to CDC.
Migraine-Related Stigma Impacts Quality of Life: Daily Dose
Updated Monovalent COVID-19 Vaccines Effective Against Symptomatic Infection, Emerging Variants
The updated COVID-19 vaccines were approximately 54% effective against symptomatic SARS-CoV-2 infection, according to new data from the CDC.
HbA1c Greater than 6.0% Raises T2D Risk in Children with Obesity: Daily Dose
Depression Severity Linked to Higher Odds of Asthma, COPD, and Respiratory Symptoms
The risk of cough and asthma in persons with severe depression was 3.32 times and 2.84 times higher, respectively, than that in those without depression, reported researchers.
Gabapentinoid Use Increasing in US: Daily Dose
FDA Renews Warning Against Use of Tianeptine-Containing Products, aka “Gas Station Heroin”
Reported adverse events of products with tianeptine include seizures, loss of consciousness, and death, according to the FDA.
Daily Dose: Outpatient C. difficile Underdiagnosed in US
Dupilumab Safe for Patients with Moderate-to-Severe Asthma for up to 6 Years
New data suggest that dupilumab is safe for long-term use among patients with moderate-to-severe asthma or OCS-dependent severe asthma.
Daily Dose: Vaccination Reduces Risk of Long COVID in Children
Daily Dose: Gabapentinoids & Risk of Severe COPD Exacerbations
